Bupikomid

Bupikomid
	5-Butil-2-piridinkarboksamid
Drugi nazivi	Sch-10595; Fusaramide
Identifikacija
CAS registarski broj	22632-06-0
PubChem	31447
ChemSpider	29167
UNII	0X3H76N0HY
Jmol-3D slike	Slika 1
SMILES
	O=C(c1ncc(cc1)CCCC)N
InChI
	InChI=1S/C10H14N2O/c1-2-3-4-8-5-6-9(10(11)13)12-7-8/h5-7H,2-4H2,1H3,(H2,11,13) ; Kod: VKSPIPWLHGKJQO-UHFFFAOYSA-N InChI=1/C10H14N2O/c1-2-3-4-8-5-6-9(10(11)13)12-7-8/h5-7H,2-4H2,1H3,(H2,11,13); Kod: VKSPIPWLHGKJQO-UHFFFAOYAT
Svojstva
Molekulska formula	C10H14N2O
Molarna masa	178.23 g mol−1
	; ; Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje (25 °C, 100 kPa) materijala
	Infobox references

Bupikomid je hemijsko jedinjenje koje je razvilo i proizvodi preduzeće Lanospharma Laboratories Company, Ltd. Ono se eksperimentalno koristi kao beta blokator i kao jak vazodilatator. Nuspojave bupikomida su redukovani sistolni, dijastolni i srednji arterijski pritisak.^[5]^[6]

Reference[uredi | uredi kod]

↑ Bupicomide, Chemical Book
↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Chrysant, SG; Adamopoulos, P; Tsuchiya, M; Frohlich, ED (1976). „Systemic and renal hemodynamic effects of bupicomide: A new vasodilator”. American heart journal 92 (3): 335–9. PMID 782220.
↑ Velasco, M; Gilbert, CA; Rutledge, CO; McNay, JL (1975). „Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: A comparison with hydralazine”. Clinical pharmacology and therapeutics 18 (2): 145–53. PMID 1097150.

Spoljašnje veze[uredi | uredi kod]

Portal Hemija

[1] Bupicomide, Chemical Book

[2] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[3] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[4] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

[5] Chrysant, SG; Adamopoulos, P; Tsuchiya, M; Frohlich, ED (1976). „Systemic and renal hemodynamic effects of bupicomide: A new vasodilator”. American heart journal 92 (3): 335–9. PMID 782220.

[6] Velasco, M; Gilbert, CA; Rutledge, CO; McNay, JL (1975). „Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: A comparison with hydralazine”. Clinical pharmacology and therapeutics 18 (2): 145–53. PMID 1097150.

[1]

[2]

[3]

[4]

[5]

[6]

Bupikomid

Reference[uredi | uredi kod]

Spoljašnje veze[uredi | uredi kod]

Navigacija

Pretraga